Division of Hematology and Oncology

November 3, 2016

Study details rare heart risk of certain cancer therapies

By VUMC News and Communications
October 20, 2016

VICC trial putting lung cancer therapy to the test

Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.

By VUMC News and Communications
August 17, 2016

Chicken Salad Chick Foundation gift to support Vanderbilt-Ingram Cancer Center research

Chicken Salad Chick Foundation founding board members Stacy Brown and Betty and Earlon McWhorter presented a $200,000 check to Vanderbilt-Ingram Cancer Center (VICC) to support cancer research. Among other initiatives, the Chicken Salad Chick Foundation was proud to host Music and Miracles Superfest, the first major stadium concert in Jordan-Hare’s 75-year history, held on April 23 in Auburn, Alabama.

By VUMC News and Communications
June 22, 2016

Lovly tapped to brief Congress on cancer research

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science.

By Doug Campbell
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.

By VUMC News and Communications
A smiling woman in her 50s in front of a rock wall.
April 21, 2016

Study explores how some breast cancers resist treatment

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

By VUMC News and Communications
March 31, 2016

Vanderbilt Asthma, Sinus, Allergy Program sees uptick in alpha-gal syndrome

Vanderbilt’s Asthma, Sinus, and Allergy Program has seen an increase in the number of patients being treated for alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.
March 24, 2016

Singer’s concert honors care received at Cancer Center

A cancer patient’s gratitude toward his Vanderbilt-Ingram Cancer Center (VICC) physician led to a star-studded concert to benefit the Cancer Center.
By VUMC News and Communications
March 17, 2016

One Million Strong event to raise awareness about colorectal cancer

Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer.
By VUMC News and Communications
March 3, 2016

Melanoma response to immune therapy

Melanoma-specific expression of a certain protein identifies tumors that are more responsive to an immune therapy.
By Leigh MacMillan
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
By VUMC News and Communications
January 21, 2016

Lovly lands cancer research grant from V Foundation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.
By VUMC News and Communications
January 14, 2016

VICC helps expand cancer patient’s treatment options

Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have.
By VUMC News and Communications
1 … 10 11 12 13 14 15